Master of Biopharmaceutical Engineering
University of Adelaide, The
Type of institution: University/Higher Education Institution
Level: Postgraduate
CRICOS: 00123M
Biopharmaceuticals have a critical role to play in improving global health. Recently, the development of mRNA and DNA vaccines to combat the COVID-19 pandemic has brought the work of biopharmaceutical engineers further into the public spotlight. The more effectively and efficiently these powerful vaccines or medicines can be designed and produced, the more lives they will save. With the biopharmaceuticals market valued at approximately $325.17 billion USD in 2020, professionals with specialist biopharmaceutical engineering training are in demand worldwide. Our Master of Biopharmaceutical Engineering will prepare you to take up the challenge.
Structure
- To qualify for the degree of the Master of Biopharmaceutical Engineering, students must satisfactorily complete a program of study with a combined total of 48 units. If undertaking the Research Pathway, students must complete: Core courses to the value of 24 units
- Elective courses to the value of 6 units
- and a major Research Project to the value of 18 units.
Standard entry requirements
A completed Bachelor's degree or equivalent in the field of Science, Engineering, Technology or related backgrounds with a minimum GPA of 4.5.
Study information
| Campus | Fees | Mid year intake | Attendance |
|---|---|---|---|
| North Terrace | International: $97,000 | No |
|
